Project Grant R01DA060859
Award Date
4/1/25
Completion Date
1/31/30
Dollars Obligated
$704K
Federal Agency
National Institute on Drug Abuse
Awardee
Duke University (TP7EK8DZV6N5)
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Durham, NC 27710, USA
Similar Awards
This National Institute on Drug Abuse (NIDA) project grant under the Drug Use and Addiction Research Programs (CFDA 93.279) will provide $241,500 in funding to Duke University from September 2024 to July 2027. The project aims to evaluate the effects of switching people who smoke and have opioid use disorder and chronic pain to very low nicotine content (VLNC) cigarettes. The research will use ecological momentary assessments to examine how VLNC cigarette use impacts the bidirectional...
This National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) project grant award, with CFDA number 93.279 for Drug Use and Addiction Research Programs, provides $154,568 in funding to The Washington University in St. Louis to conduct research on the role of endogenous opioids in the dorsal raphe nucleus (DRN) and their contribution to motivational and affective behavioral dysfunction during chronic pain. The 3.5-year project, running from June 2025 to December 2028, aims...
This federal Project Grant award, totaling $1,336,946, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The award will fund research at the University of California, Los Angeles (UCLA) to investigate the role of the habenula brain circuit in cigarette smoking and tobacco use disorder (TUD).
The key objectives of the project are to: 1) examine habenula functional connectivity with the salience network and ventral...
This $340,000 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research at the Washington University in St. Louis to investigate the role of excitatory glutamatergic inputs from the ventral tegmental area (VTA) to the locus coeruleus-noradrenergic (LC-NE) system in fentanyl withdrawal-induced negative affective behaviors. The overall goal is to better understand the contribution of the LC-NE system...
This National Institutes of Health National Institute on Drug Abuse Project Grant award of $234,364.35 supports research from March 1, 2021 through August 31, 2022 at clinical practices of the University of Pennsylvania located in Pennsylvania. The research aims to characterize a nociception-active basolateral amygdala to anterior cingulate cortex circuit that contributes to affective-attention pain behaviors, and determine its overlap with endogenous mu opioid receptor systems. The grant...
The Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse awarded $858,000 under the Drug Abuse and Addiction Research Programs (CFDA 93.279) to Western University of Health Sciences from June 2022 through May 2025. The Project Grant will support research examining pain-induced impulsivity in rats and its underlying mechanisms. Specifically, the awardee will introduce a rodent model of the cognitive component of pain using a delay discounting...
This $1,525,066 Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will support research focused on understanding the complex mechanisms underlying chronic pain. The study aims to elucidate how somatosensory, cognitive, and affective information is integrated in corticothalamic brain networks to produce the experience of chronic pain. Through direct...
This $373,181 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under CFDA Program 93.279 "Drug Use and Addiction Research Programs" will fund research at Miami University to investigate the role of cholinergic interneurons in regulating opioid-related behaviors.
The key objectives are to determine 1) whether mu-opioid receptors on cholinergic interneurons contribute to opioid reward and withdrawal, and 2) whether these receptors regulate dopamine release during...
This $14.2 million project grant from the National Institute of Neurological Disorders and Stroke, part of the Department of Health and Human Services, will fund research from September 2022 to August 2025 under the Drug Abuse and Addiction Research Programs (CFDA 93.279).
The Massachusetts General Hospital will investigate the mechanisms by which spinal cord stimulation reduces pain, with the goal of improving device design and patient selection. Researchers will apply specialized nerve...
This federal Project Grant award, valued at $238,276, was provided by the National Institute of Neurological Disorders and Stroke under the Drug Abuse and Addiction Research Programs (CFDA 93.279). The funding supports research at the University of California, Irvine to investigate the role of the enzyme N-acylethanolamine acid amidase (NAAA) in the development of hyperalgesic priming, a model for studying the transition from acute to chronic pain. The project aims to identify the receptor...